chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Pruritus, Vaccination site induration, Vaccination site mass
Clinical narrative: Few little bumpy places; Itchy; Swelling up around the site goes to her elbow; Warm; Round solid area, large and hard; Redness; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Few little bumpy places), ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm soreness), PRURITUS (Itchy) and VACCINATION SITE INDURATION (Round solid area, large and hard) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Drug allergy (Tinasil). Concomitant products included PANTOPRAZOLE for Acid reflux (oesophageal), CETIRIZINE for Allergy, APIXABAN for Anticoagulant therapy, AMIODARONE for Atrial fibrillation, ATORVASTATIN and COLESTIPOL for Cholesterol, LISINOPRIL for Hypertension, LEVOTHYROXINE SODIUM (L THYROXINE) for Hypothyroidism, ALENDRONATE SODIUM (FOSAMAX) for Osteoporosis, METHOTREXATE SODIUM (METOTREXATE), FOLIC ACID and INFLIXIMAB (REMICADE) for Rheumatoid arthritis.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE INDURATION (Round solid area, large and hard). On 04-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm). On 05-Mar-2021, the patient experienced VACCINATION SITE MASS (Few little bumpy places), PRURITUS (Itchy) and VACCINATION SITE SWELLING (Swelling up around the site goes to her elbow). At the time of the report, VACCINATION SITE MASS (Few little bumpy places), ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm soreness), PRURITUS (Itchy), VACCINATION SITE INDURATION (Round solid area, large and hard), VACCINATION SITE WARMTH (Warm) and VACCINATION SITE SWELLING (Swelling up around the site goes to her elbow) outcome was unknown.            Concomitant medications were not provided. Treatment details include cortisone cream.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Few little bumpy places; Itchy; Swelling up around the site goes to her elbow; Warm; Round solid area, large and hard; Redness; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Few little bumpy places), ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm soreness), PRURITUS (Itchy) and VACCINATION SITE INDURATION (Round solid area, large and hard) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Drug allergy (Tinasil). Concomitant products included PANTOPRAZOLE for Acid reflux (oesophageal), CETIRIZINE for Allergy, APIXABAN for Anticoagulant therapy, AMIODARONE for Atrial fibrillation, ATORVASTATIN and COLESTIPOL for Cholesterol, LISINOPRIL for Hypertension, LEVOTHYROXINE SODIUM (L THYROXINE) for Hypothyroidism, ALENDRONATE SODIUM (FOSAMAX) for Osteoporosis, METHOTREXATE SODIUM (METOTREXATE), FOLIC ACID and INFLIXIMAB (REMICADE) for Rheumatoid arthritis.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm soreness) and VACCINATION SITE INDURATION (Round solid area, large and hard). On 04-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm). On 05-Mar-2021, the patient experienced VACCINATION SITE MASS (Few little bumpy places), PRURITUS (Itchy) and VACCINATION SITE SWELLING (Swelling up around the site goes to her elbow). At the time of the report, VACCINATION SITE MASS (Few little bumpy places), ERYTHEMA (Redness), PAIN IN EXTREMITY (Arm soreness), PRURITUS (Itchy), VACCINATION SITE INDURATION (Round solid area, large and hard), VACCINATION SITE WARMTH (Warm) and VACCINATION SITE SWELLING (Swelling up around the site goes to her elbow) outcome was unknown.            Concomitant medications were not provided. Treatment details include cortisone cream.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M220A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness in the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
Age: 83.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Musculoskeletal stiffness, Rash pruritic
Clinical narrative: Itchy rash; Stiff neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiff neck) and RASH PRURITIC (Itchy rash) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.    Co-suspect product included non-company product DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event.    The patient's past medical history included No adverse event (No relevant medical history reported).   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient started DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (unknown route) at an unspecified dose. On 02-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff neck). On 03-Mar-2021, the patient experienced RASH PRURITIC (Itchy rash). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiff neck) and RASH PRURITIC (Itchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medicines were reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Rash, Vaccination site swelling
Clinical narrative: armpit real sore; injection site really raised and swollen; rash across entire back, chest, belly, and butt crack; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (armpit real sore), RASH (rash across entire back, chest, belly, and butt crack) and VACCINATION SITE SWELLING (injection site really raised and swollen) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced RASH (rash across entire back, chest, belly, and butt crack). On an unknown date, the patient experienced AXILLARY PAIN (armpit real sore) and VACCINATION SITE SWELLING (injection site really raised and swollen). At the time of the report, AXILLARY PAIN (armpit real sore), RASH (rash across entire back, chest, belly, and butt crack) and VACCINATION SITE SWELLING (injection site really raised and swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. Treatment information was not reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: hot in the area of the injection; itchy; red; arm was a little sore for 2-3 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little sore for 2-3 days), VACCINATION SITE WARMTH (hot in the area of the injection), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included Cancer (Patient  stated that she had cancer in the lymph nodes in both armpits years ago.).    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (arm was a little sore for 2-3 days). On 02-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red). On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot in the area of the injection). At the time of the report, PAIN IN EXTREMITY (arm was a little sore for 2-3 days) had resolved and VACCINATION SITE WARMTH (hot in the area of the injection), VACCINATION SITE PRURITUS (itchy) and VACCINATION SITE ERYTHEMA (red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature increased, Chills, Cough, Fatigue
Clinical narrative: queasy; headache; chills; vomiting; fatigue; muscle pain in her legs; muscle pain in her hips; joint pains; sweats; dry cough; temperature was between 96-97 F; soreness at the injection site; "it started hitting her harder"; pain from arm to neck and base of head; This spontaneous case was reported by a patient and describes the occurrence of PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head), BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats) and COUGH (dry cough) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head) and VACCINATION SITE PAIN (soreness at the injection site). On 04-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats), COUGH (dry cough), NAUSEA (queasy), HEADACHE (headache), CHILLS (chills), VOMITING (vomiting), FATIGUE (fatigue), MYALGIA (muscle pain in her legs), MYALGIA (muscle pain in her hips) and ARTHRALGIA (joint pains). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head), BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats), COUGH (dry cough), VACCINATION SITE PAIN (soreness at the injection site), NAUSEA (queasy), HEADACHE (headache), CHILLS (chills), VOMITING (vomiting), FATIGUE (fatigue), MYALGIA (muscle pain in her legs), MYALGIA (muscle pain in her hips) and ARTHRALGIA (joint pains) outcome was unknown.            This case was linked to MOD-2021-035984 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Myalgia, Nausea, Pain
Clinical narrative: queasy; headache; chills; vomiting; fatigue; muscle pain in her legs; muscle pain in her hips; joint pains; sweats; dry cough; temperature was between 96-97 F; soreness at the injection site; "it started hitting her harder"; pain from arm to neck and base of head; This spontaneous case was reported by a patient and describes the occurrence of PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head), BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats) and COUGH (dry cough) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head) and VACCINATION SITE PAIN (soreness at the injection site). On 04-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats), COUGH (dry cough), NAUSEA (queasy), HEADACHE (headache), CHILLS (chills), VOMITING (vomiting), FATIGUE (fatigue), MYALGIA (muscle pain in her legs), MYALGIA (muscle pain in her hips) and ARTHRALGIA (joint pains). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head), BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats), COUGH (dry cough), VACCINATION SITE PAIN (soreness at the injection site), NAUSEA (queasy), HEADACHE (headache), CHILLS (chills), VOMITING (vomiting), FATIGUE (fatigue), MYALGIA (muscle pain in her legs), MYALGIA (muscle pain in her hips) and ARTHRALGIA (joint pains) outcome was unknown.            This case was linked to MOD-2021-035984 (Patient Link).
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain, Vomiting
Clinical narrative: queasy; headache; chills; vomiting; fatigue; muscle pain in her legs; muscle pain in her hips; joint pains; sweats; dry cough; temperature was between 96-97 F; soreness at the injection site; "it started hitting her harder"; pain from arm to neck and base of head; This spontaneous case was reported by a patient and describes the occurrence of PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head), BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats) and COUGH (dry cough) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032M20A and 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head) and VACCINATION SITE PAIN (soreness at the injection site). On 04-Mar-2021, the patient experienced BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats), COUGH (dry cough), NAUSEA (queasy), HEADACHE (headache), CHILLS (chills), VOMITING (vomiting), FATIGUE (fatigue), MYALGIA (muscle pain in her legs), MYALGIA (muscle pain in her hips) and ARTHRALGIA (joint pains). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN ("it started hitting her harder"), PAIN IN EXTREMITY (pain from arm to neck and base of head), BODY TEMPERATURE INCREASED (temperature was between 96-97 F), HYPERHIDROSIS (sweats), COUGH (dry cough), VACCINATION SITE PAIN (soreness at the injection site), NAUSEA (queasy), HEADACHE (headache), CHILLS (chills), VOMITING (vomiting), FATIGUE (fatigue), MYALGIA (muscle pain in her legs), MYALGIA (muscle pain in her hips) and ARTHRALGIA (joint pains) outcome was unknown.            This case was linked to MOD-2021-035984 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Patient had sore arm after receiving 1st dose of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Patient had sore arm after receiving 1st dose of vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Patient had sore arm after receiving 1st dose of vaccine). At the time of the report, VACCINATION SITE PAIN (Patient had sore arm after receiving 1st dose of vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Upon internal review on 21-May-2021, the age was corrected to unknown.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm hurts). At the time of the report, PAIN IN EXTREMITY (Arm hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Fatigue, Headache, Myalgia
Clinical narrative: pain on her left arm; dizzy; headache; muscle aches; nausea/felt like throwing up; felt tired; fever (T102F); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain on her left arm), DIZZINESS (dizzy), HEADACHE (headache), MYALGIA (muscle aches) and NAUSEA (nausea/felt like throwing up) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had Covid-19 last week of Oct2020 until early part of Nov2020 for which she was hospitalized for 5 days.) and COVID-19 pneumonia.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain on her left arm), DIZZINESS (dizzy), HEADACHE (headache), MYALGIA (muscle aches), NAUSEA (nausea/felt like throwing up), FATIGUE (felt tired) and PYREXIA (fever (T102F)). On 05-Mar-2021, PYREXIA (fever (T102F)) had resolved. At the time of the report, PAIN IN EXTREMITY (pain on her left arm), DIZZINESS (dizzy), HEADACHE (headache), MYALGIA (muscle aches), NAUSEA (nausea/felt like throwing up) and FATIGUE (felt tired) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 102f (High) Body temperature-high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia
Clinical narrative: pain on her left arm; dizzy; headache; muscle aches; nausea/felt like throwing up; felt tired; fever (T102F); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain on her left arm), DIZZINESS (dizzy), HEADACHE (headache), MYALGIA (muscle aches) and NAUSEA (nausea/felt like throwing up) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had Covid-19 last week of Oct2020 until early part of Nov2020 for which she was hospitalized for 5 days.) and COVID-19 pneumonia.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain on her left arm), DIZZINESS (dizzy), HEADACHE (headache), MYALGIA (muscle aches), NAUSEA (nausea/felt like throwing up), FATIGUE (felt tired) and PYREXIA (fever (T102F)). On 05-Mar-2021, PYREXIA (fever (T102F)) had resolved. At the time of the report, PAIN IN EXTREMITY (pain on her left arm), DIZZINESS (dizzy), HEADACHE (headache), MYALGIA (muscle aches), NAUSEA (nausea/felt like throwing up) and FATIGUE (felt tired) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 102f (High) Body temperature-high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site swelling
Clinical narrative: Lump at the site of vaccination; Swelling at the site of vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Lump at the site of vaccination) and VACCINATION SITE SWELLING (Swelling at the site of vaccination) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001AZ1A) for COVID-19 vaccination.     No Medical History was provided by the reporter.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Mar-2021, the patient experienced VACCINATION SITE MASS (Lump at the site of vaccination) and VACCINATION SITE SWELLING (Swelling at the site of vaccination). On 06-Mar-2021, VACCINATION SITE MASS (Lump at the site of vaccination) and VACCINATION SITE SWELLING (Swelling at the site of vaccination) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Outcome of the events are updated.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety
Clinical narrative: Anxiety; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Anxiety). At the time of the report, ANXIETY (Anxiety) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: vaccine was administered and some of the vaccine leaked out; vaccine was administered and some of the vaccine leaked out; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (vaccine was administered and some of the vaccine leaked out) and DEVICE CONNECTION ISSUE (vaccine was administered and some of the vaccine leaked out) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced UNDERDOSE (vaccine was administered and some of the vaccine leaked out) and DEVICE CONNECTION ISSUE (vaccine was administered and some of the vaccine leaked out). At the time of the report, UNDERDOSE (vaccine was administered and some of the vaccine leaked out) outcome was unknown and DEVICE CONNECTION ISSUE (vaccine was administered and some of the vaccine leaked out) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 05-Mar-2021: No specific follow-up information recorded. On 06-Apr-2021: NNI; Sender's Comments: This report refers to a case of Vaccine Underdose and Syringe Connection Issue for mRNA-1273, lot # 029A21A
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Influenza, Myalgia, Pain, Pyrexia
Clinical narrative: Chills; Fever; Aches and pain; aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), PAIN (Aches and pain) and MYALGIA (aches) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M014M20A) for COVID-19 immunisation.     No medical history was provided by the reporter.  The patient's past medical history included COVID-19 from 27-Dec-2020 to 10-Jan-2021 and Flu from 27-Dec-2020 to 10-Jan-2021.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), PAIN (Aches and pain) and MYALGIA (aches). On 04-Mar-2021, CHILLS (Chills), PYREXIA (Fever), PAIN (Aches and pain) and MYALGIA (aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Dec-2020, Influenza: (Positive) Positive. On 27-Dec-2020, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Chills; Fever; Aches and pain; aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), PAIN (Aches and pain) and MYALGIA (aches) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M014M20A) for COVID-19 immunisation.     No medical history was provided by the reporter.  The patient's past medical history included COVID-19 from 27-Dec-2020 to 10-Jan-2021 and Flu from 27-Dec-2020 to 10-Jan-2021.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), PAIN (Aches and pain) and MYALGIA (aches). On 04-Mar-2021, CHILLS (Chills), PYREXIA (Fever), PAIN (Aches and pain) and MYALGIA (aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Dec-2020, Influenza: (Positive) Positive. On 27-Dec-2020, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash on injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash on injection site). At the time of the report, VACCINATION SITE RASH (rash on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: TCR added. Patient hang up the call, not interested. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash on injection site). At the time of the report, VACCINATION SITE RASH (rash on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: TCR added. Patient hang up the call, not interested.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pain in extremity
Clinical narrative: Light headed when walking around/ Patient started experiencing dizziness 2 days after getting 1st dose; Soreness in the arm; Light headache 2 days after first dose; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Light headed when walking around/ Patient started experiencing dizziness 2 days after getting 1st dose), PAIN IN EXTREMITY (Soreness in the arm) and HEADACHE (Light headache 2 days after first dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (Light headed when walking around/ Patient started experiencing dizziness 2 days after getting 1st dose), PAIN IN EXTREMITY (Soreness in the arm) and HEADACHE (Light headache 2 days after first dose). At the time of the report, DIZZINESS (Light headed when walking around/ Patient started experiencing dizziness 2 days after getting 1st dose), PAIN IN EXTREMITY (Soreness in the arm) and HEADACHE (Light headache 2 days after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication taken by patient was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Mar-2021: Follow-up attached. Added concomitant medication Updated suspect drug information. Added new events
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Fever of 100.4F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever of 100.4F) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever of 100.4F). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Pain in extremity, at an unspecified dose and frequency and IBUPROFEN for Fever and Pain in extremity, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) and PYREXIA (Fever of 100.4F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Body temperature: 100.4 (High) 100.4 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm hurt a little bit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt a little bit) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt a little bit). At the time of the report, PAIN IN EXTREMITY (Arm hurt a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-035688 (Patient Link).
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure via skin contact, Underdose
Clinical narrative: Some of the vaccine it ran down his arm; Some of the vaccine it ran down his arm; A spontaneous report was received from a consumer concerning a 79-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and some of the vaccine ran down his arm (Vaccine underdose, exposure via skin contact).  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 22 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Batch Number 030l20a) intramuscularly for prophylaxis of COVID-19 infection.  On 22 Jan 2021, the nurse administered vaccine to the patient and some of the vaccine it ran down his arm (Vaccine underdose, exposure via skin contact).  No treatment information was provided.   The patient received both scheduled doses of mRNA-1273, therefore action taken with the drug in response to the events was not applicable.  The outcome of the event the vaccine ran down his arm (Vaccine underdose, exposure via skin contact) was considered resolved on 22 Jan 2021.; Reporter's Comments: This report refers to a case of Vaccine underdose and exposure via skin contact for mRNA-1273, lot # 030I20a with no associated AEs.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Has not received second shot; A spontaneous report was received from a 59-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced has not received second shot.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13-JAN-2021, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 027L20A) intramuscularly for prophylaxis of COVID-19 infection. The patient had not received the second shot yet.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of event has not received second shot was unknown.  The reporter did not provide the assessment for the event, has not received second shot.; Reporter's Comments: This report refers to a case of Product dose omission issue for mRNA-1273, lot # unknown, with no associated AEs.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Pain in extremity, Palpitations, Urticaria
Clinical narrative: hives down both her legs/hives down both arms and both legs/just a little bump here and there; pain in her arm; chills/a little bit of chills; heart racing; anxiety; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives down both her legs/hives down both arms and both legs/just a little bump here and there), PAIN IN EXTREMITY (pain in her arm), PALPITATIONS (heart racing), ANXIETY (anxiety) and CHILLS (chills/a little bit of chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.    Co-suspect product included non-company product OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) (unknown route) 20 mg. On 01-Mar-2021, the patient experienced URTICARIA (hives down both her legs/hives down both arms and both legs/just a little bump here and there), PAIN IN EXTREMITY (pain in her arm) and CHILLS (chills/a little bit of chills). In 2021, the patient experienced PALPITATIONS (heart racing) and ANXIETY (anxiety). At the time of the report, URTICARIA (hives down both her legs/hives down both arms and both legs/just a little bump here and there), PALPITATIONS (heart racing) and ANXIETY (anxiety) had resolved and PAIN IN EXTREMITY (pain in her arm) and CHILLS (chills/a little bit of chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-063165 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 16-Mar-2021: followup received on 16-mar-2021 significant information was reported On 04-Jun-2021: other manufacture report; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-063165:1st dose
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Lymphadenopathy, Rash erythematous, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Red rash; Itchiness; Injection site induration; Swelling of lymph nodes; Swelling; Injection site has pain; Injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash), VACCINATION SITE PRURITUS (Itchiness), INJECTION SITE INDURATION (Injection site induration), LYMPHADENOPATHY (Swelling of lymph nodes) and VACCINATION SITE SWELLING (Swelling) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), VACCINATION SITE PRURITUS (Itchiness), INJECTION SITE INDURATION (Injection site induration), LYMPHADENOPATHY (Swelling of lymph nodes), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PAIN (Injection site has pain) and VACCINATION SITE PAIN (Injection site tenderness). At the time of the report, RASH ERYTHEMATOUS (Red rash), VACCINATION SITE PRURITUS (Itchiness), INJECTION SITE INDURATION (Injection site induration), LYMPHADENOPATHY (Swelling of lymph nodes), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PAIN (Injection site has pain) and VACCINATION SITE PAIN (Injection site tenderness) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up received on 02MAY2021, does not contain no new information and patient stated that she is fine.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Red rash; Itchiness; Injection site induration; Swelling of lymph nodes; Swelling; Injection site has pain; Injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash), VACCINATION SITE PRURITUS (Itchiness), INJECTION SITE INDURATION (Injection site induration), LYMPHADENOPATHY (Swelling of lymph nodes) and VACCINATION SITE SWELLING (Swelling) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red rash), VACCINATION SITE PRURITUS (Itchiness), INJECTION SITE INDURATION (Injection site induration), LYMPHADENOPATHY (Swelling of lymph nodes), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PAIN (Injection site has pain) and VACCINATION SITE PAIN (Injection site tenderness). At the time of the report, RASH ERYTHEMATOUS (Red rash), VACCINATION SITE PRURITUS (Itchiness), INJECTION SITE INDURATION (Injection site induration), LYMPHADENOPATHY (Swelling of lymph nodes), VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PAIN (Injection site has pain) and VACCINATION SITE PAIN (Injection site tenderness) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable. No concomitant medications reported by investigator  No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Follow up received on 02MAY2021, does not contain no new information and patient stated that she is fine.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Facial pain, Neck pain, Pain
Clinical narrative: tachycardia; left side severe pain radiating up on the left arm; left shoulder; left neck; left chest; left side of the face; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (left side severe pain radiating up on the left arm), ARTHRALGIA (left shoulder), NECK PAIN (left neck), CHEST PAIN (left chest) and FACIAL PAIN (left side of the face) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Atrial fibrillation, High cholesterol and Hypertension. Concomitant products included APIXABAN for Anticoagulant therapy, FLECAINIDE for Atrial fibrillation, ATORVASTATIN for Cholesterol, SPIRONOLACTONE and OLMESARTAN for Hypertension.    On 26-Feb-2021 at 12:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (left side severe pain radiating up on the left arm), ARTHRALGIA (left shoulder), NECK PAIN (left neck), CHEST PAIN (left chest) and FACIAL PAIN (left side of the face). On 05-Mar-2021, the patient experienced TACHYCARDIA (tachycardia). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (left side severe pain radiating up on the left arm), ARTHRALGIA (left shoulder), NECK PAIN (left neck), CHEST PAIN (left chest), FACIAL PAIN (left side of the face) and TACHYCARDIA (tachycardia) outcome was unknown.            Concomitant medications Flecainide, Eloquis, Spirinolactone, Atorvastatin, Olmesartan. Treatment details include Tylenol, cool pads. Hospital: Hydration and series of dx tests.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: tachycardia; left side severe pain radiating up on the left arm; left shoulder; left neck; left chest; left side of the face; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (left side severe pain radiating up on the left arm), ARTHRALGIA (left shoulder), NECK PAIN (left neck), CHEST PAIN (left chest) and FACIAL PAIN (left side of the face) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Atrial fibrillation, High cholesterol and Hypertension. Concomitant products included APIXABAN for Anticoagulant therapy, FLECAINIDE for Atrial fibrillation, ATORVASTATIN for Cholesterol, SPIRONOLACTONE and OLMESARTAN for Hypertension.    On 26-Feb-2021 at 12:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (left side severe pain radiating up on the left arm), ARTHRALGIA (left shoulder), NECK PAIN (left neck), CHEST PAIN (left chest) and FACIAL PAIN (left side of the face). On 05-Mar-2021, the patient experienced TACHYCARDIA (tachycardia). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (left side severe pain radiating up on the left arm), ARTHRALGIA (left shoulder), NECK PAIN (left neck), CHEST PAIN (left chest), FACIAL PAIN (left side of the face) and TACHYCARDIA (tachycardia) outcome was unknown.            Concomitant medications Flecainide, Eloquis, Spirinolactone, Atorvastatin, Olmesartan. Treatment details include Tylenol, cool pads. Hospital: Hydration and series of dx tests.